Dutasteride and Bicalutamide Most comfortable Injectable
Dual 5-Alpha Reductase Inhibitor for Androgenetic Alopecia (AGA)
Androgenetic alopecia is primarily driven by dihydrotestosterone (DHT), which shortens the anagen phase and leads to progressive follicular miniaturization. Dutasteride inhibits both Type I and Type II 5-alpha reductase enzymes, resulting in a significant reduction in scalp DHT levels and improved follicular preservation. Liposomal delivery enhances follicular targeting while minimizing systemic exposure